Dr. Habib R Khan, MD
Claim this profileLondon Health Sciences Centre
Area of expertise
Sudden Cardiac Death
Habib R Khan, MD has run 2 trials for Sudden Cardiac Death. Some of their research focus areas include:
Arrhythmia
Habib R Khan, MD has run 2 trials for Arrhythmia. Some of their research focus areas include:
Affiliated Hospitals
London Health Sciences Centre
London Health Sciences Centre - University Hospital
Clinical Trials Habib R Khan, MD is currently running
Tideglusib
for Arrhythmogenic Cardiomyopathy
The TaRGET study is a multi-centre, prospective, randomized, double-blind, placebo-controlled trial designed to evaluate the potential therapeutic efficacy of tideglusib, a glycogen synthase kinase-3 β inhibitor, in genotype positive arrhythmogenic cardiomyopathy.
Recruiting
0 awards
Phase 2
Diagnostic Test
for CRDS
Calcium Release Deficiency Syndrome (CRDS) is a novel inherited arrhythmia syndrome secondary to RyR2 loss-of-function that confers a risk of sudden cardiac death. Diagnosis of CRDS presently requires cellular-based in vitro confirmation that an RyR2 variant causes loss-of-function. We hypothesize that CRDS can be diagnosed clinically through evaluation of the repolarization response to brief tachycardia, mediated by cardiac pacing, and a subsequent pause.
Recruiting
1 award
N/A
More about Habib R Khan, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Habib R Khan, MD has experience with
- Tideglusib
- Pacing
- AV Node Ablation
- CRT
- Left Bundle Branch Area Pacing
Breakdown of trials Habib R Khan, MD has run
Sudden Cardiac Death
Left Ventricular Cardiomyopathy
Arrhythmogenic Cardiomyopathy
Right Ventricular Cardiomyopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Habib R Khan, MD specialize in?
Habib R Khan, MD focuses on Sudden Cardiac Death and Arrhythmia. In particular, much of their work with Sudden Cardiac Death has involved RyR2 positive patients, or patients who are PKP2 positive.
Is Habib R Khan, MD currently recruiting for clinical trials?
Yes, Habib R Khan, MD is currently recruiting for 2 clinical trials in London Ontario. If you're interested in participating, you should apply.
Are there any treatments that Habib R Khan, MD has studied deeply?
Yes, Habib R Khan, MD has studied treatments such as Tideglusib, Pacing, AV node ablation.
What is the best way to schedule an appointment with Habib R Khan, MD?
Apply for one of the trials that Habib R Khan, MD is conducting.
What is the office address of Habib R Khan, MD?
The office of Habib R Khan, MD is located at: London Health Sciences Centre, London, Ontario N6A 5A5 Canada. This is the address for their practice at the London Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.